Earnings live: ASML, Morgan Stanley stocks rise on strong earnings
Morgan Stanley shares rose alongside ASML after both companies reported strong earnings, putting the focus on whether the initial reactions can hold. For MS, the limited enrichment points to modest 3.2% revenue growth and $10.21 diluted EPS, leaving follow-through dependent on the quality and durability of earnings rather than the headline beat alone.
What happened
Morgan Stanley shares rose alongside ASML after both companies reported strong earnings, putting the focus on whether the initial reactions can hold.
The read · Jul 15
MS is testing whether strong earnings can support a durable rerating despite only modest reported revenue growth, while ASML adds broader earnings momentum to the tape.
Wrong if
The angle fails if subsequent guidance and business-line commentary show stronger forward earnings momentum than the headline data implies, or if the initial rally broadens into sustained sector support.
CoverageFirst reported by Yahoo Finance at 8:24 AM ET · the only report so farHow this is decided →
The chart · MSTradingView · third-party feed, not the Wire’s licensed closes
🔒 Click to interact · scroll moves the page
The story1 min read
Morgan Stanley shares moved higher in a broader earnings update that also highlighted strength at ASML. The supplied company data shows Morgan Stanley generated $5.3 billion in revenue for fiscal 2025, up 3.2% year over year, with diluted EPS of $10.21. No detailed segment results, guidance, analyst consensus, or price-reaction data were provided for MS.
The setup matters because a positive earnings-day move can either mark a durable reassessment of earnings power or simply reflect relief around the reported numbers. Morgan Stanley is the directly enriched ticker in this story, while ASML is mentioned in the headline but has no supporting figures here.
The bullish case rests on strong reported earnings and the stock’s positive initial response. The countercase is that 3.2% revenue growth is not obviously high-growth, and without guidance, business-line detail, or valuation context it is difficult to determine whether the move fully prices in the result.
The next signals are management’s outlook, fee and trading trends, capital-markets activity, and whether MS sustains the post-earnings gain after the wider earnings session is digested.
The read, in fullWhy it matters
The headline and positive share reaction provide a constructive signal, but the supplied MS data shows only 3.2% year-over-year revenue growth and offers no guidance, consensus, valuation, or segment detail. That leaves the durability of the earnings reaction unresolved rather than supporting a clean directional trade.
The arc● Open · no developments yet
· Published
The read above, as written. kept as written · closes shown from JUL 15 on
Next · what would move this
Into the next 1-2 weeks of post-earnings trading. Follow to be told when one lands.
Since this story · named here, equal weight · 1D EOD-6.0%
JUL 15 · first close after publicationAUG 28
Price context does not establish that the story caused the move.
▲ The case it holds
Strong reported earnings and a positive market reaction could signal that Morgan Stanley’s $10.21 diluted EPS reflects improving earnings power that is not captured by the modest 3.2% revenue-growth figure alone.
▼ The case it breaks
The 3.2% revenue increase is modest, and absent guidance or consensus data there is a credible risk that the earnings-day strength reflects a headline reaction rather than a durable upgrade to MS’s outlook.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →